If you liked this article you might like

Mylan Investors Reject Executive Pay Proposal, A Major Blow to the EpiPen Maker
How Does Mylan Cut Its Tax Bill? By Investing in Coal
A Lot Can Go Right For Mylan, But Cantor Isn't Sure That It Will
Biotech Movers: Adamis Shares Jump After FDA Approves Epinephrine Pre-filled Syringe